AN
AN2 Therapeutics, Inc.
ANTX · NASDAQ
$5.73 -4.82% (-$0.29)
1M -2.39%
Market Cap $206.4M
P/E Ratio -
Div. Yield -
ROE 53.52%
Bulios Fair Price
$3.82
33.3% downside
Trenutna cena
$5.73
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ANTX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
71 /100
Cheap P/B 2.72x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 17.75%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 51.01%
ROE 53.52%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 14.32x
Int. coverage N/A
Stability
57 /100
Moderate Beta -0.99x
EPS volatility 19.25%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ANTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric E. Easom
Employees
21
Headquarters
Menlo Park
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report